The European Medicines Agency (EMA) has approved the use of Bavarian Nordic’s mpox vaccine in adolescents, increasing the ...

Mpox, declared a global public health emergency by WHO, has disproportionately affected children and adolescents ...

Gavi, the Vaccine Alliance, will purchase 500,000 doses of MVA-BN, the Bavarian Nordic Mpox vaccine, as part of an ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

The vaccination campaign against mpox in the Democratic Republic of Congo is to begin on October 2, the public health ...

The Ministry of Health on September 19 announced that it launched an Mpox vaccination campaign for health workers, cross-border business operators, hospitality workers, and other high-risk groups.

COPENHAGEN, Denmark I 19, 2024 I Bavarian Nordic A/S (OMX: BAVA) announced today that the European Commission has adopted the Committee for ...

With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

African experts have estimated the continent might need about 10 million vaccines to stop the ongoing outbreaks ...

As advised in a recent Euro Weekly News article, the number of cases of Mpox in Spain is currently in decline. Unfortunately, ...

Health Minister of Indian state of Kerala, Veena George, said on Thursday that genome sequencing will be conducted to ...

The Democratic Republic of Congo, the epicenter of an mpox outbreak, on Thursday, received its first vaccines — almost half ...